{
    "Trade/Device Name(s)": [
        "Dimension Vista\u2122 System Drugs of Abuse Positive Control (UDAT CON (+) - KCS15)",
        "Dimension Vista\u2122 System Drugs of Abuse Negative Control (UDAT CON (-) - KC516)"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K062191",
    "Predicate Device Reference 510(k) Number(s)": [
        "K950138"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "DIF"
    ],
    "Summary Letter Date": "July 27, 2006",
    "Summary Letter Received Date": "July 31, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical Toxicology Control Material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamines/Methamphetamines",
        "Barbiturates",
        "Benzodiazepines",
        "Cocaine Metabolite",
        "Methadone",
        "Opiates",
        "Phencyclidine",
        "Cannabinoids"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista System"
    ],
    "Method(s)/Technology(ies)": [
        "Gas Chromatography/Mass Spectrometry (GC/MS)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista System Drugs of Abuse Positive and Negative Controls for urine-based toxicology quality control on Dimension Vista System",
    "Indications for Use Summary": "In vitro diagnostic quality control product for Amphetamines/Methamphetamines, Barbiturates, Benzodiazepines, Cocaine Metabolite, Methadone, Opiates, Phencyclidine, and Cannabinoids methods on the Dimension Vista System",
    "fda_folder": "Toxicology"
}